Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Erlotinib in Combination With Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel/Carboplatin With or Without Cetuximab in CUP
- Status
- UNKNOWN
- Phase
- PHASE2
Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer
- Status
- TERMINATED
- Phase
- NA
A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC
- Status
- TERMINATED
- Phase
- PHASE1
Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Status
- COMPLETED
- Phase
- PHASE2
Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Sorafenib/Cetuximab in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2